Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,185-2,196 of 10,612
Drug study icon
CompletedNCT02133001

Intranasal Esketamine for depression

This study is completed in the United States. It is testing intranasal Esketamine for depression.

In United States
Depression, SuicidalityDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedEUCTR 2018-002782-19

A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRE...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Allergan Ltd.
Condition
Depression
Drug study icon
CompletedNCT00518323

Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia

This study is completed in the United States, in India, in Romania, .... It is testing Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia.

In United States
SchizophreniaDrugFrom 12 Years to 17 Years
Countries
United States, India, Romania, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT01094249

Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia

This study is completed in the United States. It is testing Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia.

In United States
Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.